Concurrent chemoradiotherapy versus radiotherapy alone in postoperative high-risk adenoid cystic carcinoma of the head and neck: A propensity score matched analysis
The addition of concurrent chemotherapy to postoperative IMRT did not confer a survival benefit in terms of LRRFS, DMFS, DFS, or OS in patients with head and neck ACC. Upcoming results from randomized studies are anticipated to shed more light on this debated issue. CCRT should be avoided outside of clinical trials.
Authors
- Ying Xiao (ORCID: https://orcid.org/0000-0002-3294-4407)
- Yu Wang (ORCID: https://orcid.org/0000-0001-5547-1668)
- Lulu Ye
- Shengjin Dou (ORCID: https://orcid.org/0000-0002-6530-641X)
- Guopei Zhu (ORCID: https://orcid.org/0000-0003-4770-9458)
- Lin Zhang (ORCID: https://orcid.org/0000-0002-7515-5248)
- Rongrong Li (ORCID: https://orcid.org/0009-0001-7550-5869)
- Wen Hui Jiang (ORCID: https://orcid.org/0000-0002-4824-3883)
- Yining He
- Xin Wang (ORCID: https://orcid.org/0009-0009-0444-1704)
- Shengwen Liu
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Ninth People's Hospital (CN)
- Shanghai Second People's Hospital (CN)
- National Clinical Research (US)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1016/j.ctro.2025.100945
- Citations
- 3
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.02
Funders
- Adenoid Cystic Carcinoma Research Foundation